Literature DB >> 29358277

Intracellular BH3 Profiling Reveals Shifts in Antiapoptotic Dependency in Human B Cell Maturation and Mitogen-Stimulated Proliferation.

Joanne Dai1, Micah A Luftig2.   

Abstract

Apoptosis is critical to B cell maturation, but studies of apoptotic regulation in primary human B cells is lacking. In this study, we sought to better understand the mechanisms of apoptotic regulation in normal and activated B cells. Using intracellular BH3 profiling, we defined the Bcl2 dependency of B cell subsets from human peripheral blood and tonsillar lymphoid tissue as well as mitogen-activated B cells. We found that naive and memory B cells were BCL-2-dependent, whereas germinal center B cells were MCL-1-dependent and plasma cells were BCL-XL-dependent. B cells stimulated to proliferate ex vivo by CpG or CD40L/IL-4 became more dependent on MCL-1 and BCL-XL As B cell lymphomas often rely on survival mechanisms derived from normal and activated B cells, these findings offer new insight into potential therapeutic strategies for lymphomas.
Copyright © 2018 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29358277      PMCID: PMC5821561          DOI: 10.4049/jimmunol.1701473

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  47 in total

1.  Proliferation and survival of activated B cells requires sustained antigen receptor engagement and phosphoinositide 3-kinase activation.

Authors:  Amber C Donahue; David A Fruman
Journal:  J Immunol       Date:  2003-06-15       Impact factor: 5.422

2.  BH3 mimetics antagonizing restricted prosurvival Bcl-2 proteins represent another class of selective immune modulatory drugs.

Authors:  Emma M Carrington; Ingela B Vikstrom; Amanda Light; Robyn M Sutherland; Sarah L Londrigan; Kylie D Mason; David C S Huang; Andrew M Lew; David M Tarlinton
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-01       Impact factor: 11.205

3.  Bcl-6 mediates the germinal center B cell phenotype and lymphomagenesis through transcriptional repression of the DNA-damage sensor ATR.

Authors:  Stella Maris Ranuncolo; Jose M Polo; Jamil Dierov; Michael Singer; Tracy Kuo; John Greally; Roland Green; Martin Carroll; Ari Melnick
Journal:  Nat Immunol       Date:  2007-06-10       Impact factor: 25.606

4.  BH3 profiling identifies three distinct classes of apoptotic blocks to predict response to ABT-737 and conventional chemotherapeutic agents.

Authors:  Jing Deng; Nicole Carlson; Kunihiko Takeyama; Paola Dal Cin; Margaret Shipp; Anthony Letai
Journal:  Cancer Cell       Date:  2007-08       Impact factor: 31.743

5.  Developmental Regulation of Mitochondrial Apoptosis by c-Myc Governs Age- and Tissue-Specific Sensitivity to Cancer Therapeutics.

Authors:  Kristopher A Sarosiek; Cameron Fraser; Nathiya Muthalagu; Patrick D Bhola; Weiting Chang; Samuel K McBrayer; Adam Cantlon; Sudeshna Fisch; Gail Golomb-Mello; Jeremy A Ryan; Jing Deng; Brian Jian; Chris Corbett; Marti Goldenberg; Joseph R Madsen; Ronglih Liao; Dominic Walsh; John Sedivy; Daniel J Murphy; Daniel Ruben Carrasco; Shenandoah Robinson; Javid Moslehi; Anthony Letai
Journal:  Cancer Cell       Date:  2016-12-22       Impact factor: 31.743

6.  iBH3: simple, fixable BH3 profiling to determine apoptotic priming in primary tissue by flow cytometry.

Authors:  Jeremy Ryan; Joan Montero; James Rocco; Anthony Letai
Journal:  Biol Chem       Date:  2016-07-01       Impact factor: 3.915

7.  Burkitt's lymphoma is a malignancy of mature B cells expressing somatically mutated V region genes.

Authors:  U Klein; G Klein; B Ehlin-Henriksson; K Rajewsky; R Küppers
Journal:  Mol Med       Date:  1995-07       Impact factor: 6.354

8.  Relative mitochondrial priming of myeloblasts and normal HSCs determines chemotherapeutic success in AML.

Authors:  Thanh-Trang Vo; Jeremy Ryan; Ruben Carrasco; Donna Neuberg; Derrick J Rossi; Richard M Stone; Daniel J Deangelo; Mark G Frattini; Anthony Letai
Journal:  Cell       Date:  2012-10-12       Impact factor: 41.582

9.  Designed BH3 peptides with high affinity and specificity for targeting Mcl-1 in cells.

Authors:  Glenna Wink Foight; Jeremy A Ryan; Stefano V Gullá; Anthony Letai; Amy E Keating
Journal:  ACS Chem Biol       Date:  2014-07-23       Impact factor: 5.100

10.  Functional disparities among BCL-2 members in tonsillar and leukemic B-cell subsets assessed by BH3-mimetic profiling.

Authors:  Victor Peperzak; Erik Slinger; Johanna Ter Burg; Eric Eldering
Journal:  Cell Death Differ       Date:  2016-09-30       Impact factor: 15.828

View more
  2 in total

1.  WEE1 Inhibition Enhances Anti-Apoptotic Dependency as a Result of Premature Mitotic Entry and DNA Damage.

Authors:  Mathilde Rikje Willemijn de Jong; Myra Langendonk; Bart Reitsma; Pien Herbers; Marcel Nijland; Gerwin Huls; Anke van den Berg; Emanuele Ammatuna; Lydia Visser; Tom van Meerten
Journal:  Cancers (Basel)       Date:  2019-11-07       Impact factor: 6.639

2.  Apoptotic Blocks in Primary Non-Hodgkin B Cell Lymphomas Identified by BH3 Profiling.

Authors:  Ryan N Rys; Claudia M Wever; Dominique Geoffrion; Christophe Goncalves; Artin Ghassemian; Eugene Brailovski; Jeremy Ryan; Liliana Stoica; Josée Hébert; Tina Petrogiannis-Haliotis; Svetlana Dmitrienko; Saul Frenkiel; Annette Staiger; German Ott; Christian Steidl; David W Scott; Pierre Sesques; Sonia Del Rincon; Koren K Mann; Anthony Letai; Nathalie A Johnson
Journal:  Cancers (Basel)       Date:  2021-02-28       Impact factor: 6.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.